David Kirske
Director of Finance/CFO at CTI BIOPHARMA CORP.
Profile
David H.
Kirske is currently the CFO, Secretary & Executive Vice President at CTI BioPharma Corp.
He previously held positions as the Chief Financial Officer & Vice President at Helix BioMedix, Inc., Treasurer & Controller at Redhook Ale Brewery, Inc., and Treasurer & Controller at F5, Inc. Mr. Kirske completed his undergraduate degree at the University of Puget Sound.
David Kirske active positions
Companies | Position | Start |
---|---|---|
CTI BIOPHARMA CORP. | Director of Finance/CFO | 2017-09-25 |
Former positions of David Kirske
Companies | Position | End |
---|---|---|
HELIX BIOMEDIX, INC. | Director of Finance/CFO | 2008-06-22 |
Redhook Ale Brewery, Inc. | Comptroller/Controller/Auditor | - |
F5, INC. | Comptroller/Controller/Auditor | - |
Training of David Kirske
University of Puget Sound | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
HELIX BIOMEDIX, INC. | Health Technology |
F5, INC. | Technology Services |
Private companies | 2 |
---|---|
CTI BioPharma Corp.
CTI BioPharma Corp. Pharmaceuticals: MajorHealth Technology CTI BioPharma Corp. is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of novel targeted therapies for blood-related cancers. It focuses on evaluating pacritinib, its sole product candidate currently in active development, for the treatment of adult patients with myelofibrosis. The company was founded by James A. Bianco, Jack W. Singer, and Louis A. Bianco in September 1991 and is headquartered in Seattle, WA. | Health Technology |
Redhook Ale Brewery, Inc. | Consumer Non-Durables |
- Stock Market
- Insiders
- David Kirske